We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





AI-Powered COVID-19 Cough Analyzer App Assesses Respiratory Health and Associated Risks

By LabMedica International staff writers
Posted on 28 Aug 2020
A team of scientists have repurposed an artificial intelligence/machine learning-powered cough analysis mobile app for assessing respiratory health and associated COVID-19 risks.

The mobile app called kAs has been developed by Zensark Technologies (Hyderabad, Telangana, India), in collaboration with Salcit Technologies (Hyderabad, Telangana, India), to assess respiratory health of the patients by leveraging machine learning and disease specific cough signatures. More...
It brings the functionality of Spirometry using one's smartphone to carry out on demand assessments without the need to step out of the house. Patients can use their mobile phones to track the sound of their cough to assess and track their health.

The app has been developed based on the guidelines laid out by the WHO and asks 15 questions to the subject. The subject then cough into the mobile app which sends the cough sounds to the company’s AI platform Swaasa, where it undergoes an audiometric analysis and produces a composite COVID Risk Score, based on the answers to the questionnaire and the coughing sound. The app generates a rating on a scale of 1 to 10, with 10 being the highest risk level. The Risk Score of any individual can be tracked across multiple days or weeks. The subjects can be asked to submit cough samples as many times a day for as many days as necessary. Based on the samples and symptoms, the app tracks the risk level of each individual over time.

Anytime a subject is found to be breaching a threshold risk score, it is highlighted to public health officials on their dashboards. The dashboards are designed to show the population level statistics and can drill down to the detailed reports of an individual subject. The app also allows doctors, with an external microphone and wireless stethoscope to track various breathing and risk parameters.

Related Links:
Zensark Technologies
Salcit Technologies



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
New
Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Research has linked platelet aggregation in midlife blood samples to early brain markers of Alzheimer’s (Photo courtesy of Shutterstock)

Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk

Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more

Microbiology

view channel
Image: Development of targeted therapeutics and diagnostics for extrapulmonary tuberculosis at University Hospital Cologne (Photo courtesy of Michael Wodak/Uniklinik Köln)

Blood-Based Molecular Signatures to Enable Rapid EPTB Diagnosis

Extrapulmonary tuberculosis (EPTB) remains difficult to diagnose and treat because it spreads beyond the lungs and lacks easily accessible biomarkers. Despite TB infecting 10 million people yearly, the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.